Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

SULLIVAN ANDREW F

2. Date of Event Requiring Statement (MM/DD/YYYY) 12/1/2019

3. Issuer Name and Ticker or Trading Symbol

PRUDENTIAL FINANCIAL INC [PRU]

(Last) (First) (Middle)

751 BROAD STREET, 4TH FLOOR, ATTN: CORPORATE COMPLIANCE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Executive Vice President /

(Street)

NEWARK, NJ 07102

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7517	D
Common Stock	338	I	By 401(k)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
2015 Employee Stock Option (Right to Buy)	⁽¹⁾	2/10/2025	Common Stock	826	$78.08	D
5/15/15 Employee Stock Option (Right to Buy)	⁽²⁾	5/15/2025	Common Stock	344	$85.46	D
10/13/15 Employee Stock Option (Right to Buy)	⁽³⁾	10/13/2025	Common Stock	749	$77.15	D
2016 Employee Stock Option (Right to Buy)	⁽⁴⁾	2/9/2026	Common Stock	2524	$63.59	D
2017 Employee Stock Option (Right to Buy)	⁽⁵⁾	2/14/2027	Common Stock	2577	$110.45	D
2017 Performance Shares	⁽⁶⁾	⁽⁶⁾	Common Stock	1992	$0 ⁽⁷⁾	D
10/2/17 Employee Stock Option (Right to Buy)	⁽⁸⁾	10/2/2027	Common Stock	1128	$107.28	D
10/2/2017 Performance Shares	⁽⁶⁾	⁽⁶⁾	Common Stock	872	$0 ⁽⁷⁾	D
2018 Employee Stock Option (Right to Buy)	⁽⁹⁾	2/13/2028	Common Stock	3251	$106.89	D
2018 Performance Shares	⁽¹⁰⁾	⁽¹⁰⁾	Common Stock	2462	$0 ⁽⁷⁾	D
2019 Employee Stock Option (Right to Buy)	⁽¹¹⁾	2/12/2029	Common Stock	7022	$93.36	D
2019 Performance Shares	⁽¹²⁾	⁽¹²⁾	Common Stock	4499	$0 ⁽⁷⁾	D
Deferred Compensation Shares	⁽¹³⁾	⁽¹³⁾	Common Stock	1574	$0 ⁽¹⁴⁾	D

Explanation of Responses:
(1)	The options vest in three equal annual installments beginning February 10, 2016.
(2)	The options vest in three equal annual installments beginning on May 15, 2016.
(3)	The options vest in three equal annual installments beginning on October 13, 2016.
(4)	The options vest in three equal annual installments beginning on February 9, 2017.
(5)	The options vest in three equal annual installments beginning on February 14, 2018.
(6)	Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2017 through 2019 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2020.
(7)	The performance shares convert to common stock on a 1 to 1 basis.
(8)	The options vest in three equal annual installments beginning on October 2, 2018.
(9)	The options vest in three equal annual installments beginning on February 13, 2019.
(10)	Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2018 through 2020 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2021.
(11)	The options vest in three equal annual installments beginning on February 12, 2020.
(12)	Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022.
(13)	Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant.
(14)	Deferred Compensation Shares are based on unitized accounting and convert to common stock on a 1 to 1 basis.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
SULLIVAN ANDREW F 751 BROAD STREET, 4TH FLOOR ATTN: CORPORATE COMPLIANCE NEWARK, NJ 07102			Executive Vice President